Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4 - Montecucco, F; Braunersreuther, V; Burger, F (Thromb Haemost, 2015)
et al.